Faron Updates Positive Clinical Data from Phase I/II BEXMAB

Faron Updates Positive Clinical Data from Phase I/II BEXMAB Study of Bexmarilimab in Relapsed/Refractory AML and MDS BEXMAB Study Update

Faron Updates Positive Clinical Data from Phase I/II BEXMAB Study of Bexmarilimab in Relapsed/Refractory AML and MDS BEXMAB Study Update

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Finland , Helsinki , Eteläuomen Läi , Boston , Massachusetts , United States , Jukka , Lapland , Jenniferc Smith Parker , Christopher Golden , Sandy Jamieson , Juha Karttunen , Jo Turner , Mika Kontro , Peel Hunt , Head Of Communications , Faron Pharmaceuticals Ltd , Helsinki University Hospital Comprehensive Cancer Center , European Hematology Association , Faron Pharmaceuticals , Cairn Financial Advisers , Biologics License Application , First North , Study Update , Associate Professor , Principal Investigator , Chief Medical Officer , Investor Relations Calendar , Certified Adviser , Nasdaq First ,